Treatment of central nervous system (CNS) malignancies typically involves radiotherapy to forestall tumor growth and recurrence following surgical resection. Despite the many benefits of cranial radiotherapy, survivors often suffer from a wide range of debilitating and progressive cognitive deficits. Thus, while patients afflicted with primary and secondary malignancies of the CNS now experience longer local regional control and progression-free survival, there remains no clinical recourse for the unintended neurocognitive sequelae associated with their cancer treatments. Multiple mechanisms contribute to disrupted cognition following irradiation, including the depletion of radiosensitive populations of stem and progenitor cells in the hipp...
For the majority of CNS malignancies, radiotherapy provides the best option for forestalling tumor g...
With the exception of survival, cognitive impairment stemming from the clinical management of cancer...
With the exception of survival, cognitive impairment stemming from the clinical management of cancer...
Treatment of central nervous system (CNS) malignancies typically involves radiotherapy to forestall ...
Past preclinical studies have demonstrated the capability of using human stem cell transplantation i...
Past preclinical studies have demonstrated the capability of using human stem cell transplantation i...
Past preclinical studies have demonstrated the capability of using human stem cell transplantation i...
Past preclinical studies have demonstrated the capability of using human stem cell transplantation i...
Radiotherapy often provides the only clinical recourse for those afflicted with primary or metastati...
Radiotherapy often provides the only clinical recourse for those afflicted with primary or metastati...
Past preclinical studies have demonstrated the capability of using human stem cell transplantation i...
PurposeRadiotherapy remains a primary treatment modality for the majority of central nervous system ...
PurposeRadiotherapy remains a primary treatment modality for the majority of central nervous system ...
PurposeRadiotherapy remains a primary treatment modality for the majority of central nervous system ...
For the majority of CNS malignancies, radiotherapy provides the best option for forestalling tumor g...
For the majority of CNS malignancies, radiotherapy provides the best option for forestalling tumor g...
With the exception of survival, cognitive impairment stemming from the clinical management of cancer...
With the exception of survival, cognitive impairment stemming from the clinical management of cancer...
Treatment of central nervous system (CNS) malignancies typically involves radiotherapy to forestall ...
Past preclinical studies have demonstrated the capability of using human stem cell transplantation i...
Past preclinical studies have demonstrated the capability of using human stem cell transplantation i...
Past preclinical studies have demonstrated the capability of using human stem cell transplantation i...
Past preclinical studies have demonstrated the capability of using human stem cell transplantation i...
Radiotherapy often provides the only clinical recourse for those afflicted with primary or metastati...
Radiotherapy often provides the only clinical recourse for those afflicted with primary or metastati...
Past preclinical studies have demonstrated the capability of using human stem cell transplantation i...
PurposeRadiotherapy remains a primary treatment modality for the majority of central nervous system ...
PurposeRadiotherapy remains a primary treatment modality for the majority of central nervous system ...
PurposeRadiotherapy remains a primary treatment modality for the majority of central nervous system ...
For the majority of CNS malignancies, radiotherapy provides the best option for forestalling tumor g...
For the majority of CNS malignancies, radiotherapy provides the best option for forestalling tumor g...
With the exception of survival, cognitive impairment stemming from the clinical management of cancer...
With the exception of survival, cognitive impairment stemming from the clinical management of cancer...